Educational Opportunities

TransplantCARE Homepage » Health Plan » Educational Opportunities » AATMC » AATMC Online Course » Session 2 Case Studies in Heart Failure » Session Test

Session Test

Instructions:

Please remember to enter your name and email below. 

If this is your first try leave the Retest Code  field blank, complete each question, and then hit submit.  The form will go blank and you will receive a confirmation email.  If you do not receive this confirmation of submission by the next morning email us at aatmc@interlinkhealth.com

Please allow 1 - 2 business days processing time.  You will then receive a pass or fail confirmation.

If you receive a fail confirmation the email will include a retest code.  Come back to this page, enter your name, email, and the Retest Code to complete the test again.




 

Health Plan

Email
Name
Retest Code
1. Which of the following best describes the current status of intra-aortic balloon pumps as a support device for acute heart failure:
2. Reports published in the last 10 years on survival of patients with Stage D (NYHA Class IV) heart failure treated with optimal medical management show which of the following:
3. The first implanted mechanical circulatory device into a human was about
4. Continuous flow models of mechanical heart assist devices are known to be:
5. Patients with the congenital heart disease called hypoplastic left heart syndrome may need which of the following after all corrective surgeries possible have been done:
6. Of all patients who receive heart transplant, which of these is the most limiting factor for long term survival of the graft?
7. Since the Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) started receiving data on device implantation, the slope of the change in volume over those 8 years shows:
8. The REMATCH trial that was instrumental in the FDA’s decision to approve destination therapy devices showed the survival outcomes at 12 months between those managed medically or those provided destination therapy with a continuous flow assist device to be:
9. The evolution of LVAD mechanical assist devices seems to be heading all but which of the following directions
10. Among the challenges remaining for mechanical circulatory support (MCS), the following remain problematic